Bares Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bares Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-8,808	Closed	-$970K	–	48
2014 Q4	$970K	Hold	8,808	–	–	0.12%	31
2014 Q3	$860K	Hold	8,808	–	–	0.11%	33
2014 Q2	$888K	Hold	8,808	–	–	0.07%	41
2014 Q1	$809K	Buy	+8,808	New	+$812K	0.06%	45
2013 Q4	–	Sell	-8,808	Closed	-$702K	–	68
2013 Q3	$702K	Hold	8,808	–	–	0.07%	49
2013 Q2	$641K	Buy	+8,808	New	+$659K	0.06%	51

Other funds holding ZBH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bares Capital Management's ZBH Position: Q1 2015 in Review

Bares Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2015, closing a stake of 8,808 shares — an estimated $970K sold.

Bares Capital Management first reported a position in ZBH in Q2 2013 and held it in 6 quarters. The position peaked at $970K in Q4 2014. 762 funds tracked by Wall St. Rank hold ZBH as of Q1 2015.

Bares Capital Management reported no remaining Zimmer Biomet position as of Q1 2015 after selling out during the quarter.
Bares Capital Management sold 8,808 Zimmer Biomet shares in Q1 2015, an estimated $970K.
Bares Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 6 quarters.
Bares Capital Management's Zimmer Biomet position peaked at $970K in Q4 2014.
762 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2015.

Based on Bares Capital Management's 13F filing for Q1 2015, filed 15 May 2015.